Việt Nam applies gene therapy to cancer treatment – Viet Nam News
Viet Nam News |
Việt Nam applies gene therapy to cancer treatment
Viet Nam News HÀ NỘI – Việt Nam has begun implementing gene and immune cell therapies, with the goal of tailoring cancer treatments to individual patients. According to Tạ Thành Văn, Vice Principal of Hà Nội Medical University (HMU), the university has successfully … |
Press Telegraph |
Editas Medicine Receives EMA’s Orphan Medicinal Product …
Markets Insider CAMBRIDGE, Mass., Sept. 26, 2017 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the … Editas Medicine, Inc. (NASDAQ:EDIT) Moving Today – Down $0.85First News 24 |
FOX10 News |
Immunotherapy cancer treatment at MCI
FOX10 News A promising way to fight cancer is catching the attention of many people across the United States. Immunotherapy involves the removal of immune cells and boosting a person’s natural defenses. The cells are then released back into the bloodstream to … |
Medical News Bulletin |
Which Genes are Essential for Cancer Immunotherapy?
Medical News Bulletin The CRISPR-Cas9 screening method has identified the genes that play a role in the body’s immune response to tumors. This important discovery will help to improve the results of cancer immunotherapy. |
|
Editas Medicine Receives EMA’s Orphan Medicinal Product Designation for EDIT-101 for the Treatment of LCA10
P&T Community 26, 2017 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced the European Medicines Agency (EMA) granted Orphan Medicinal Product designation to EDIT-101, a pre-clinical, CRISPR-based … Editas Medicine, Inc. (NASDAQ:EDIT) Closed Higher Than Its 50 Day AverageFirst News 24 |